Engineered treatment
to reduce atherosclerosis

Trialed and tested

Reduction in cholesterol and other lipids
Plaque reduction within 4 weeks

Cavadex reverses heart disease

Cavadex is NOT A DRUG

  • Cavadex is a ring-shaped starch that absorbs cholesterol from artery walls.

  • Unlike most drugs, Cavadex is not broken down and absorbed in the body.

  • Cavadex circulates around the vascular system collecting cholesterol and leaves the body intact via urine.

  • Cavadex has no side effects because it is not metabolized in the body.

  • Cyclodextrins have been used safely in medicine for over 30 years and are FDA approved.

RemChol tubes contain Cavadex

  • RemChol tubes remove plaque from the arteries.

  • Angina is reduced within 2 weeks.

  • Plaque substantially reduced within 3 months.

  • RemChol requires no lifestyle changes to be effective.

  • RemChol can be safely self-administered at home.

Some of the worlds leading Doctors and Professors confirm CAVADEX reverses heart disease

USA cardiologist Dr. James Roberts MD FACC FAARFM

Cavadex reverses Heart Disease

USA cardiologist Dr. Roberts has been treating his patients for almost 2 years.

"Now that we have Cavadex we can directly remove the plaque"
"Cavadex is directly reversing the arterial disease"
"Cavadex is a universal antidote to atherosclerosis"
"Our patients get better in 2 weeks with Cavadex"
"Rapid onset of biochemical benefit"
"Slow but steady reduction in plaque volume"
"Cavadex improves lower extremity and brain blood flow"
"Cavadex is incredibly safe, you can’t hurt anyone with Cavadex"

Australian Professor Laurie Howes MB BS PhD FRACP FCSANZ

Cavadex reduces plaque

Head of cardiovascular research at one of Australia’s largest hospitals. Preeminent Consultant Physician (Cardiology) Professor of Pharmacology and Therapeutics at two of Australia’s leading universities

"Improving vascular inflammation"
"Cavadex has more safety data than statins when they were introduced"
"This is the greatest advance we have had in cardiovascular pharmacology for the treatment of atheroma plaques since statins"

Leading medical professionals agree

RemChol works on everyone!

  • No matter what your lifestyle, RemChol reduces plaque and removes cholesterol from arterial walls.

  • RemChol can only benefit your health, it can’t harm you.

  • People using RemChol report improvement within 2 weeks.

  • Other products claim they MAY or COULD improve your health, RemChol WILL improve your health.

  • We are saving lives everyday with RemChol

Leading cardiac research professors...

  • ‘Cavadex is one of the greatest medical breakthroughs of our time’

  • ‘greatest breakthrough treatment for atherosclerosis since the discovery of statins’

Leading Doctors and cardiologists...

  • ‘now that we have Cavadex, we can directly remove plaque’

  • ‘Cavadex is a universal antidote to atherosclerosis’

  • ‘This will save the medical industry trillions of dollars, Why hasn’t this been researched earlier?’

  • ‘If everyone had access to Cavadex we could rid the world of heart disease within 12 months’

Patients are getting better

Douw has been using RemChol for 18 months.

No more need for by-pass surgery
Douw was facing triple by-pass surgery. 18 months later his arteries are clear.
This is a MUST see testimonial

Start your treatment today

Remchol for home use

CAVADEXTRIN® can only be absorbed into the blood stream when administered as an IV or as an enema.
RemChol delivers CAVADEXTRIN® via an enema.
Each tube contains 8 grams of CAVADEXTRIN® with over 2 grams absorbed into the blood stream with every treatment.

Remchol tubes can be administered as often as twice a day.

Patients using RemChol report :

Reduction of Angina within 2-4 weeks
Significant reduction of plaque within 2-3 months
No side-effects

Available now

RemChol patient

Helga's calcium score went down.

RemChol lowers calcium score within weeks
Helga had a calcium score test and it was very high
After just 9 weeks using RemChol her score
dropped from 591 down to 521

CAVADEXTRIN reverses Heart Disease

CAVADEXTRIN® reduces lipid levels and arterial plaque within 4 weeks.

CAVADEXTRIN® reduces atherosclerosis

CAVADEXTRIN® captures cholesterol and transports the cholesterol out of the body in the urine.


In 2016, German scientists discovered that a compound “Cyclodextrin” reduced arterial plaque in mice. Cholrem Pty Ltd researched cyclodextrins and engineered a specific cyclodextrin with enhanced cholesterol transport capabilities. This new cyclodextrin "CAVADEXTRIN®" is a ring-shaped structure made from starch. CAVADEXTRIN® is only several atoms wide and has a cavity in the middle. The outside of the ring is attracted to water and the inside cavity is attracted to oils and lipids (like cholesterol).

When CAVADEXTRIN® circulates around the vascular system, cholesterol is sucked into the cavity and the cholesterol binds with the CAVADEXTRIN® and is transported out of the body via the urine.

Science Articles


Cyclodextrin reprogrammed the cells in plaques, leading to increased transport of the dissolved cholesterol away from the plaques...

Science Daily

Cyclodextrin dissolves cholesterol crystals and reduces atherosclerotic plaques...

Huffington Post

can actually solubilize cholesterol and dissolve the plaques...

Science Daily

Soaked up cholesterol and removed it...

Norwegian University of Science and Technology

have the potential in lowering deaths caused by atherosclerosis...

CAVADEXTRIN® removes plaque and cholesterol

plaque reduced in just 4 weeks

A recent study by the University Hospital in Bonn, Germany discovered that cyclodextrin melts away cholesterol crystals (the main cause of arterial plaque that clogs arteries) and reduced existing plaque within just 4 weeks. The cyclodextrin bound to and dissolved the cholesterol crystals from the plaque of mice, leading to transport of the dissolved cholesterol away from the plaques. The same effects were seen in human plaque samples treated with cyclodextrin.

Article : Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming

Improve Liver function

Another study by the University of Texas Southwestern Medical Center, Dallas, Texas, shows the treatment of Npc1-deficient mice slows cholesterol sequestration in major organs and improves liver function. This study shows that cyclodextrin is effective in mobilizing entrapped cholesterol in late stage NPC disease leading to improved liver function.

Article : Systemic administration of 2-hydroxypropyl-B-cyclodextrin to symptomatic Npc1-deficient mice slows cholesterol sequestration in the major organs and improves liver function.

Cyclodextrin has shown to extend lifespan by almost 10% in mice

Mice treated with CAVADEXTRIN® showed higher neurological scores than compared with the mice given saline only..

Mice on CAVADEXTRIN® lived 10% longer.

CAVADEXTRIN® cleares the vascular system and can extend lifespan.

In 2014 at the University of Texas Southwest Medical Center, a study was conducted on the effects of Cyclodextrin administered to mice. They studied the lifespan of mice treated systemically with either saline or Cyclodextrin at weekly intervals starting at 49 days of age until death. In each case, half of the males and females were given Cyclodextrin and the remaining mice received only saline.

During the study, the mice were graded on their neurological function. There were no gender related differences in the neurological scores. This score, which broadly measures neurological function, declines as the animal’s condition deteriorates.
It is clear that Cyclodextrin treated mice showed higher neurological scores than compared with the mice given saline only.

All the mice given saline only had died by 98 days whereas the majority of those receiving Cyclodextrin died in the week following. This shows an almost 10% improvement in lifespan.

The human trial of CAVADEXTRIN conducted by Cholrem has consistantly shown the scientific evidence proving the benefits of Cyclodextrin on mice also has simular benefits on humans. It would be fair to assume that based on the science, humans treated with CAVADEXTRIN would also experience a simular benefit of lifespan extention as the mice.